litlas
ログインアカウント作成

Stanley Cohen

1954–2025 年に発表

198
論文数
58,652
被引用数
121
h 指数
197
i10 指数

被引用数

Stanley Cohen の年別被引用数1967 年: 被引用 11 件1968 年: 被引用 9 件1969 年: 被引用 9 件1970 年: 被引用 21 件1971 年: 被引用 22 件1972 年: 被引用 38 件1973 年: 被引用 25 件1974 年: 被引用 65 件1975 年: 被引用 85 件1976 年: 被引用 99 件1977 年: 被引用 141 件1978 年: 被引用 176 件1979 年: 被引用 278 件1980 年: 被引用 268 件1981 年: 被引用 286 件1982 年: 被引用 378 件1983 年: 被引用 390 件1984 年: 被引用 510 件1985 年: 被引用 406 件1986 年: 被引用 360 件1987 年: 被引用 285 件1988 年: 被引用 265 件1989 年: 被引用 267 件1990 年: 被引用 206 件1991 年: 被引用 177 件1992 年: 被引用 172 件1993 年: 被引用 129 件1994 年: 被引用 174 件1995 年: 被引用 129 件1996 年: 被引用 154 件1997 年: 被引用 151 件1998 年: 被引用 151 件1999 年: 被引用 163 件2000 年: 被引用 155 件2001 年: 被引用 163 件2002 年: 被引用 166 件2003 年: 被引用 175 件2004 年: 被引用 202 件2005 年: 被引用 209 件2006 年: 被引用 223 件2007 年: 被引用 258 件2008 年: 被引用 329 件2009 年: 被引用 348 件2010 年: 被引用 343 件2011 年: 被引用 359 件2012 年: 被引用 346 件2013 年: 被引用 279 件2014 年: 被引用 275 件2015 年: 被引用 275 件2016 年: 被引用 223 件2017 年: 被引用 239 件2018 年: 被引用 250 件2019 年: 被引用 668 件2020 年: 被引用 877 件2021 年: 被引用 786 件2022 年: 被引用 560 件2023 年: 被引用 472 件2024 年: 被引用 608 件2025 年: 被引用 316 件2026 年: 被引用 7 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,957 件、この内訳の 33.2%イギリス: 引用元論文 1,302 件、この内訳の 8.7%ドイツ: 引用元論文 765 件、この内訳の 5.1%カナダ: 引用元論文 711 件、この内訳の 4.8%イタリア: 引用元論文 619 件、この内訳の 4.1%日本: 引用元論文 591 件、この内訳の 4%フランス: 引用元論文 566 件、この内訳の 3.8%中国: 引用元論文 530 件、この内訳の 3.5%オランダ: 引用元論文 493 件、この内訳の 3.3%オーストラリア: 引用元論文 439 件、この内訳の 2.9%スイス: 引用元論文 322 件、この内訳の 2.2%スペイン: 引用元論文 307 件、この内訳の 2.1%
0%33.2%その他 22.3%

機関

分野

  • Medicine56.3%
  • Biochemistry, Genetics and Molecular Biology24.3%
  • Immunology and Microbiology6.5%
  • Neuroscience4.2%
  • Social Sciences2.4%
  • Chemistry0.9%
  • その他5.4%

トピック

  • Rheumatoid Arthritis Research and Therapies7.5%
  • Spondyloarthritis Studies and Treatments3.1%
  • Monoclonal and Polyclonal Antibodies Research2.7%
  • Autoimmune and Inflammatory Disorders Research2.7%
  • Cytokine Signaling Pathways and Interactions2.2%
  • Systemic Lupus Erythematosus Research2%
  • その他79.8%

共著者

全論文

検索で開く
  1. Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis

    著者: Gerd R Burmester, Stanley Cohen, Kevin Winthrop, Peter Nash, Alan D. Irvine, Atul Deodhar, Eduardo Mysler, Yoshiya Tanaka, John Liu, Ana P. Lacerda, Hannah Palac, Tim Shaw, Philip J. Mease, Emma Guttman‐Yassky - RMD Open 2023 被引用: 210

  2. Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme

    著者: Stanley Cohen, Ronald van Vollenhoven, Kevin Winthrop, Cristiano A. F. Zerbini, Yoshiya Tanaka, Louis Bessette, Ying Zhang, Nasser Khan, Barbara A. Hendrickson, Jeffrey Enejosa, Gerd R Burmester - Annals of the Rheumatic Diseases 2020 被引用: 233

  3. Oral surveillance and JAK inhibitor safety: the theory of relativity

    著者: Kevin Winthrop, Stanley Cohen - Nature Reviews Rheumatology 2022 被引用: 196

  4. Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study

    著者: Josef S Smolen, Aileen L. Pangan, Paul Emery, William F. C. Rigby, Yoshiya Tanaka, Juan Ignacio Vargas, Ying Zhang, Nemanja Damjanov, Alan Friedman, Mohamed I. A. Othman, Heidi S. Camp, Stanley Cohen - The Lancet 2019 被引用: 378

  5. Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis

    著者: Ronald van Vollenhoven, Roy Fleischmann, Stanley Cohen, Eun Bong Lee, Juan A. García Meijide, Sylke Wagner, Šárka Forejtová, Samuel H. Zwillich, David Gruben, Tamás Koncz, Gene V. Wallenstein, Sriram Krishnaswami, John Bradley, Bethanie Wilkinson - New England Journal of Medicine 2012 被引用: 939

  6. Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial evaluating primary efficacy and safety at twenty‐four weeks

    著者: Stanley Cohen, Paul Emery, Maria Greenwald, Maxime Dougados, Richard Furie, Mark C. Genovese, Edward Keystone, J. Loveless, Gerd‐Rüdiger Burmester, Matthew Cravets, E. Hessey, T Shaw, Mark C. Totoritis - Arthritis & Rheumatism 2006 被引用: 1,640

  7. Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programme

    著者: Stanley Cohen, Yoshiya Tanaka, Xavier Mariette, Jeffrey R. Curtis, Eun Bong Lee, Peter Nash, Kevin Winthrop, Christina Charles‐Schoeman, Lisy Wang, Connie Chen, Kenneth Kwok, Pinaki Biswas, Andrea Shapiro, Ann Madsen, J. Wollenhaupt - RMD Open 2020 被引用: 181

  8. Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study

    著者: J. Wollenhaupt, Eun-Bong Lee, Jeffrey R. Curtis, Joel C. Silverfield, Ketti K. Terry, Koshika Soma, Chris Mojcik, Ryan DeMasi, Sander Strengholt, Kenneth Kwok, Irina Lazariciu, Lisy Wang, Stanley Cohen - Arthritis Research & Therapy 2019 被引用: 320

  9. Denosumab in Postmenopausal Women with Low Bone Mineral Density

    著者: Michael R. McClung, E. Michael Lewiecki, Stanley Cohen, Michael A. Bolognese, Grattan C. Woodson, Alfred H. Moffett, Munro Peacock, Paul D. Miller, Samuel Lederman, Charles H. Chesnut, Douglas Lain, Alan Kivitz, Donna Holloway, Charlie Zhang, Mark Peterson, Pirow Bekker - New England Journal of Medicine 2006 被引用: 1,215

  10. Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data

    著者: Philip J. Mease, Christina Charles‐Schoeman, Stanley Cohen, Lara Fallon, John Woolcott, Huifeng Yun, Joel M. Kremer, Jeffrey D. Greenberg, Wendi Malley, Alina Onofrei, Keith S. Kanik, Daniela Graham, Cunshan Wang, Carol A. Connell, Hernán Valdez, Manfred Hauben, Eric Hung, Ann Madsen, Thomas V. Jones, Jeffrey R. Curtis - Annals of the Rheumatic Diseases 2020 被引用: 221

  11. Effects of a Single Intra-Articular Injection of a Microsphere Formulation of Triamcinolone Acetonide on Knee Osteoarthritis Pain

    著者: Philip G. Conaghan, David J. Hunter, Stanley Cohen, Virginia B. Kraus, Françis Berenbaum, Jay R. Lieberman, Deryk G. Jones, Andrew I. Spitzer, David S. Jevsevar, Nathaniel P. Katz, Diane J. Burgess, Joelle Lufkin, James R. Johnson, N. Bodick - Journal of Bone and Joint Surgery 2018 被引用: 172

  12. Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials

    著者: Stanley Cohen, Yoshiya Tanaka, Xavier Mariette, Jeffrey R. Curtis, Eun Bong Lee, Peter Nash, Kevin Winthrop, Christina Charles‐Schoeman, Krishan Thirunavukkarasu, Ryan DeMasi, Jamie Geier, Kenneth Kwok, Lisy Wang, Richard J. Riese, J. Wollenhaupt - Annals of the Rheumatic Diseases 2017 被引用: 395

  13. Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis

    著者: Daniel H. Solomon, Jon T. Giles, Katherine P. Liao, Paul M. Ridker, Pamela M. Rist, Robert J. Glynn, Rachel Broderick, Fengxin Lu, Meredith Murray, Kathleen M.M. Vanni, L Santacroce, Shady Abohashem, Philip M. Robson, Zahi A. Fayad, Venkatesh Mani, Ahmed Tawakol, Joan M. Bathon, Yousaf Ali, Joshua Baker, Marcy B. Bolster, Vivian Bykerk, Christina Charles-Schoeman, Cong-Qiu Chu, Stanley Cohen, Jeffrey Curtis, Jack Cush, Christina Downey, Margarita Fallena, Nazanin Firooz, Brigid Freyne, Jonathan Graf, Maria Greenwald, Diane Horowitz, Elaine Husni, Rajesh Kataria, Edward Keystone, Alan Kivitz, Joel Kremer, Robert Levin, Kristine Lohr, Elena Massarotti, Alan Matsumoto, Philip Mease, Barbara Mendez, Jeffrey Miller, Larry Moreland, Binh Nguyen, Deborah Parks, William Rigby, Jose Scher, Elena Schiopu, Beth Scholz, Guillermo Valenzuela - Annals of the Rheumatic Diseases 2022 被引用: 74

  14. Fenebrutinib Versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double‐Blind, Phase II Trial

    著者: Stanley Cohen, Katie Tuckwell, Tamiko R. Katsumoto, Rui Zhao, Joshua Galanter, Chin Lee, Julie Rae, Balázs István Tóth, Nandhini Ramamoorthi, Jason A. Hackney, Alberto Berman, Nemanja Damjanov, Dmytro Fedkov, Sławomir Jeka, Leslie W. Chinn, Michael J. Townsend, Alyssa Morimoto, Mark C. Genovese - Arthritis & Rheumatology 2020 被引用: 118

  15. The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment

    著者: Ferdinand C. Breedveld, Michael H. Weisman, Arthur F. Kavanaugh, Stanley Cohen, Karel Pavelká, Ronald van Vollenhoven, John T. Sharp, John L. Perez, G Spencer-Green - Arthritis & Rheumatism 2005 被引用: 1,786

  16. A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee

    著者: Stanley Cohen, Susanna Proudman, Alan Kivitz, Francis X. Burch, John P. Donohue, Deborah Burstein, Yu‐Nien Sun, Christopher Banfield, Michael S. Vincent, Liyun Ni, Debra Zack - Arthritis Research & Therapy 2011 被引用: 244

  17. Tofacitinib (CP‐690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve‐month data from a twenty‐four–month phase III randomized radiographic study

    著者: Désirée van der Heijde, Yoshiya Tanaka, Roy Fleischmann, Edward Keystone, Joel M. Kremer, Cristiano A. F. Zerbini, Myrna Cardiel, Stanley Cohen, Peter Nash, Yeong Wook Song, Dana Tegzová, Bradley T. Wyman, David Gruben, Birgitta Benda, Gene V. Wallenstein, Sriram Krishnaswami, Samuel H. Zwillich, John Bradley, Carol A. Connell, and the ORAL Scan Investigators - Arthritis & Rheumatism 2013 被引用: 582

  18. Artificial Intelligence in Pathology

    著者: Stanley Cohen, Richard M. Levenson, Liron Pantanowitz - American Journal Of Pathology 2021 被引用: 52

  19. Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate

    著者: Mark C. Genovese, Stanley Cohen, Larry W. Moreland, D. Lium, Sean Robbins, Richard Newmark, Pirow Bekker, for the 20000223 Study Group - Arthritis & Rheumatism 2004 被引用: 522

  20. A NERVE GROWTH-STIMULATING FACTOR ISOLATED FROM SARCOM AS 37 AND 180

    著者: Stanley Cohen, Rita Levi‐Montalcini, Viktor Hamburger - National Academy of Sciences, Proceedings of the National Academy of Sciences 1954 被引用: 527

  21. Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis

    著者: John D. Isaacs, Stanley Cohen, Paul Emery, Paul P. Tak, Jianmei Wang, Guiyuan Lei, Sarah Williams, Preeti Lal, Simon Read - Annals of the Rheumatic Diseases 2012 被引用: 196

  22. Isolation of a Mouse Submaxillary Gland Protein Accelerating Incisor Eruption and Eyelid Opening in the New-born Animal

    著者: Stanley Cohen - Journal of Biological Chemistry 1962 被引用: 2,197

  23. A Randomized, Double‐Blind, Sham‐Controlled, Clinical Trial of Auricular Vagus Nerve Stimulation for the Treatment of Active Rheumatoid Arthritis

    著者: Matthew Baker, Sarah Kavanagh, Stanley Cohen, Alan K. Matsumoto, Ara Dikranian, John Tesser, Alan Kivitz, Konstantinos Alataris, Mark C. Genovese - Arthritis & Rheumatology 2023 被引用: 33

  24. A phase IIb dose‐ranging study of the oral JAK inhibitor tofacitinib (CP‐690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone

    著者: Joel M. Kremer, Stanley Cohen, Bethanie Wilkinson, Carol A. Connell, Jonathan French, Juan J. Gómez‐Reino, David Gruben, Keith S. Kanik, Sriram Krishnaswami, Virginia Pascual‐Ramos, Gene V. Wallenstein, Samuel H. Zwillich - Arthritis & Rheumatism 2011 被引用: 347